Your browser doesn't support javascript.
loading
A double-blind, randomized, multicenter phase 2 study of prasugrel versus placebo in adult patients with sickle cell disease.
J Hematol Oncol ; 6: 17, 2013 Feb 17.
Article in En | MEDLINE | ID: mdl-23414938

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Pain / Piperazines / Thiophenes / Platelet Aggregation Inhibitors / Platelet Activation / Purinergic P2Y Receptor Antagonists / Anemia, Sickle Cell Type of study: Clinical_trials / Observational_studies / Prognostic_studies / Risk_factors_studies Limits: Adolescent / Adult / Female / Humans / Male / Middle aged Language: En Journal: J Hematol Oncol Journal subject: HEMATOLOGIA / NEOPLASIAS Year: 2013 Document type: Article Affiliation country: United States Country of publication: United kingdom

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Pain / Piperazines / Thiophenes / Platelet Aggregation Inhibitors / Platelet Activation / Purinergic P2Y Receptor Antagonists / Anemia, Sickle Cell Type of study: Clinical_trials / Observational_studies / Prognostic_studies / Risk_factors_studies Limits: Adolescent / Adult / Female / Humans / Male / Middle aged Language: En Journal: J Hematol Oncol Journal subject: HEMATOLOGIA / NEOPLASIAS Year: 2013 Document type: Article Affiliation country: United States Country of publication: United kingdom